Immunogenicity difference between the SARS coronavirus and the bat SARS-like coronavirus spike (S) proteins

Biochemical and Biophysical Research Communications

Volumn 387, Issue 2, 2009, Pages 326-329

  Zhou, Peng ^a   Han, Zhenggang ^a   Wang, Lin Fa ^b   Shi, Zhengli ^a  

^a WUHAN INSTITUTE OF VIROLOGY   (China)

^b CSIRO   (Australia)

Author keywords

DNA immunization; Immunodominant region; SL CoV; Spike protein

Indexed keywords

EPITOPE; NEUTRALIZING ANTIBODY; SARS LIKE CORONAVIRUS SPIKE PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RECEPTOR;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY TITER; ARTICLE; BAT; CONTROLLED STUDY; CROSS REACTION; DNA IMMUNIZATION; GENE CONSTRUCT; HUMAN; HUMAN CELL; IMMUNOGENICITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; SARS CORONAVIRUS; VIRUS NEUTRALIZATION; WILD TYPE;

ANIMALS; CELL LINE; CHIROPTERA; HUMANS; MEMBRANE GLYCOPROTEINS; MICE; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; VIRAL ENVELOPE PROTEINS; VIRAL VACCINES;

CORONAVIRUS; MUS; SARS CORONAVIRUS;

EID: 67949118678     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.07.025     Document Type: Article

References (9)

1. Li W., Shi Z., Yu M., Ren W., Smith C., Epstein J.H., Wang H., Crameri G., Hu Z., Zhang H., Zhang J., McEachern J., Field H., Daszak P., Eaton B.T., Zhang S., and Wang L.F. Bats are natural reservoirs of SARS-like coronaviruses. Science 310 (2005) 676-679
2. Lau S.K., Woo P.C., Li K.S., Huang Y., Tsoi H.W., Wong B.H., Wong S.S., Leung S.Y., Chan K.H., and Yuen K.Y. Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats. Proc. Natl. Acad. Sci. USA 102 (2005) 14040-14045
3. Ren W., Qu X., Li W., Han Z., Yu M., Zhou P., Zhang S.Y., Wang L.F., Deng H., and Shi Z. Difference in receptor usage between severe acute respiratory syndrome (SARS) coronavirus and SARS-like coronavirus of bat origin. J. Virol. 82 (2008) 1899-1907
4. He Y., Zhou Y., Liu S., Kou Z., Li W., Farzan M., and Jiang S. Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine. Biochem. Biophys. Res. Commun. 324 (2004) 773-781
5. He Y. Immunogenicity of SARS-CoV: the receptor-binding domain of S protein is a major target of neutralizing antibodies. Adv. Exp. Med. Biol. 581 (2006) 539-542
6. Qu X.X., Hao P., Song X.J., Jiang S.M., Liu Y.X., Wang P.G., Rao X., Song H.D., Wang S.Y., Zuo Y., Zheng A.H., Luo M., Wang H.L., Deng F., Wang H.Z., Hu Z.H., Ding M.X., Zhao G.P., and Deng H.K. Identification of two critical amino acid residues of the severe acute respiratory syndrome coronavirus spike protein for its variation in zoonotic tropism transition via a double substitution strategy. J. Biol. Chem. 280 (2005) 29588-29595
7. Aihara H., and Miyazaki J. Gene transfer into muscle by electroporation in vivo. Nat. Biotechnol. 16 (1998) 867-870
8. Hon C.C., Lam T.Y., Shi Z.L., Drummond A.J., Yip C.W., Zeng F., Lam P.Y., and Leung F.C. Evidence of the recombinant origin of a bat severe acute respiratory syndrome (SARS)-like coronavirus and its implications on the direct ancestor of SARS coronavirus. J. Virol. 82 (2008) 1819-1826
9. Becker M.M., Graham R.L., Donaldson E.F., Rockx B., Sims A.C., Sheahan T., Pickles R.J., Corti D., Johnston R.E., Baric R.S., and Denison M.R. Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice. Proc. Natl. Acad. Sci. USA 105 (2008) 19944-19949